Best Healthcare Companies in Boston, United States
The 314 best Healthcare companies in Boston, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Ziopharm Oncology.
Ranked: Best Healthcare companies in Boston
| # | Company | Disclosed funding | Last round | Employees | Founded | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Ziopharm Oncology Develops immunotherapies for the treatment of cancer and autoimmune diseases | $377M | 81 mo ago | 36 | 2003 | Kevin Boyle CEO | — | 160 patents Isophosphoramide mustard salt prodrugs for oral cancer therapy, especially glioblastoma. | — |
| 2 | Ventus Therapeutics Develops small‑molecule therapeutics for autoimmune and auto‑inflammatory diseases treatment | $300M | 52 mo ago | 76 | 2019 | — | — | 152 patents Small‑molecule inhibitors of NLRP3 inflammasome and related caspase pathways | — |
| 3 | Centessa Pharmaceuticals Developer of therapeutic programs addressing unmet needs in various disease areas | $250M | 64 mo ago | 83 83 → 157 (+89%) | 2021 | — | WordPressApple iCloud MailMicrosoft 365+31 | — | — |
| 4 | Aiolos Bio Biotech company focused on developing innovative therapies for respiratory diseases and immune conditions | $245M | 31 mo ago | — | 2023 | Elizabeth Holt Founder and VP | — | — | — |
| 5 | Blue Rock Therapeutics Stem cell therapies for cardiovascular and neurological diseases | $225M | 114 mo ago | 138 | 2016 | — | WordPressApple iCloud MailMySQL+22 | — | — |
| 6 | Jnana Therapeutics Company developing a drug discovery platform for targeting the solute carrier (SLC) family of transporters | $207M | 43 mo ago | 10 | 2017 | Joanne Kotz Co-Founder & President | — | — | — |
| 7 | Parallel Developer of cannabis based products focused on well being | $175M | 42 mo ago | 1,700 | 2014 | William Wrigley CEO | WebflowApple iCloud MailMicrosoft 365+15 | 37 patents Healthcare data management and analytics platforms for clinical sites and digital content. | — |
| 8 | Superluminal Medicines Generative biological and chemical company focused on drug discovery 57Funding top 21%Talent top 38%Market bottom 44%Partners bottom 35% All 6 signals ▾Fundingtop 21% Talenttop 38% Marketbottom 44% Partnersbottom 35% Globalbottom 29% Newsbottom 15% Funding: Raised $153M across 3 rounds · 3 rounds over 3 yrs (1.0/yr) Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 57/100 | $153M | 10 mo ago | — | 2022 | Ajay Yekkirala Co-Founder | — | — | — |
| 9 | Pieris Pharmaceuticals Therapeutics based on recombinant engineered lipocalin mimics | $119M | 59 mo ago | 127 | 2001 | — | — | — | — |
| 10 | SAGE Therapeutics Developer of drug candidates for the treatment of rare CNS disorders | $106M | 65 mo ago | 487 | 1971 | Barry Greene CEO | WordPressDrupalApple iCloud Mail+28 | 1,810 patents Neuroactive steroid compounds and formulations for treating central nervous system disorders | — |
| 11 | Imbria Pharmaceuticals Provider of therapeutics solution by translation the cellular metabolism | $90M | 7 mo ago | 4 | 2014 | David-Alexandre Gros Co-Founder & CEO | — | 161 patents Metabolic-modulating small molecules for cardiac, renal, and fibrotic disease therapy | — |
| 12 | Mercy BioAnalytics Manufacturer of diagnostic test devices | $68M | 9 mo ago | 18 | 2018 | Joseph Sedlak Co-Founder & CSO | — | 87 patents Molecular diagnostic assays and biomarkers for early cancer detection | 2 job openings · 2 launchs |
| 13 | GALY Provider of medical research labs | $62M | 23 mo ago | 22 | 2018 | Luciano Bueno Founder & CEO | ContentfulApple iCloud MailMicrosoft 365+15 | 27 patents Biotech methods for in vitro cotton fiber production and plant cell culture | 1 job opening |
| 14 | Lusaris Therapeutics Provider of neuropsychiatric treatment services | $60M | 43 mo ago | 5 | 2021 | Ed Monaghan Co-Founder & CDO | — | — | — |
| 15 | NextRNA Developer of RNA-targeted therapeutics for multiple areas | $56M | 51 mo ago | 32 | 2020 | Leon Lamas Co-Founder | — | — | — |
| 16 | InStride Health Provider of anxiety management & therapy services | $56M | 26 mo ago | 85 | 2021 | Mona Potter Co-Founder | WordPressMySQLZoho+22 | — | — |
| 17 | Restorbio Reviews beauty products, ingredients, and promotes informed skincare, hair, and body choices | $40M | 102 mo ago | 25 | 2016 | — | — | 4 patents Pharmaceutical combination therapies and immune‑enhancing drug formulations | — |
| 18 | TigaTx Provider of cancer drugs development services | $37M | 18 mo ago | 3 | 2018 | Anne Altmeyer CEO | — | 24 patents Therapeutic antibody engineering for oncology, focusing on CD20, IgA, anti‑GD2 and bispecific T‑cell engagers | — |
| 19 | General Fluidics Vitro diagnostic company | $35M | 23 mo ago | 14 | 2011 | Robert Granier CEO | — | — | 1 partnership |
| 20 | Peplib Provider of peptide drug discovery and development services for global pharmaceutical industries | $34M | 61 mo ago | 7 | 2017 | Li Sean Co-Founder | — | — | 4 job openings |
| 21 | Animol Discovery R&D company focused on manufacturing drugs for multiple therapeutic areas | $34M | 17 mo ago | 20 | 2019 | Philip Austin Co-founder and Member of Board of Directors | — | 11 patents Veterinary drugs: canine JAK inhibitors and antiparasitic cyclic depsipeptide therapeutics. | — |
| 22 | Aliada Therapeutics Provider of drug research & development services for multiple therapeutic areas | $33M | 59 mo ago | 18 | 2021 | — | — | — | — |
| 23 | Grouper Provider of fitness services | $29M | 9 mo ago | — | 2018 | Spencer Morgan Founder | WordPressApple iCloud MailGoogle Workspace+24 | — | — |
| 24 | PIH Health organization aims to fights social injustice by bringing the benefits of modern medical science | $25M | 16 mo ago | 335 | 1987 | Ophelia Dahl Co-Founder | DrupalPHPJava+39 | — | — |
| 25 | Clinton Health Access Initiative Healthcare foundation focused on dedicated to saving lives of patients | $22M | 19 mo ago | 125 | 2002 | Bill Clinton Co-Founder | WordPressMySQLPHP+32 | — | 2 job openings · 1 partnership |
| 26 | Meadowhawk Biolabs CRO focused on providing of drug discovery, pharmacology, and bioanalytical services | $20M | 23 mo ago | 35 | 2021 | — | WordPressApple iCloud MailMicrosoft 365+25 | — | — |
| 27 | Xsphera Biosciences Developer of tumor preservation platform | $20M | 48 mo ago | 23 | 2018 | Steve Remondi Co-Founder & CEO | — | — | 1 launch |
| 28 | Nexcure Provider of outpatient treatment centers focusing on CAR-T and T-cell engagers | $19M | 3 mo ago | — | 2026 | Anish More Co-Founder & CBO | — | — | — |
| 29 | Dash Bio Provider of automated bioanalysis platform for accelerated clinical drug development 40Talent top 38%Funding top 39%Global bottom 33% All 3 signals ▾Talenttop 38% Fundingtop 39% Globalbottom 33% Talent: 2 named leaders on record · 2 C-suite/founder profiles curated Funding: Raised $17.5M across 2 rounds · 2 rounds over 2 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 40/100 | $18M | 12 mo ago | — | 2024 | Ander Tallett Co-Founder & COO | — | — | — |
| 30 | Curavit Contract research organization that offers a complete suite of CRO services for decentralized clinical trials | $16M | 43 mo ago | 26 | 2019 | — | WordPressMySQLPHP+29 | — | — |
| 31 | Biosim Provider of contract based drug discovery services | $12M | 28 mo ago | 34 | 2020 | — | — | — | — |
| 32 | Carna Health Company that provides integrated point-of-care testing solutions and AI-powered technology | $11M | 5 mo ago | — | 2021 | Salvatore Viscomi Co-Founder & CEO | WebflowYouTubeMicrosoft Advertising+12 | — | 1 award |
| 33 | Pepper Provider of services for drug discovery and development services | $11M | 30 mo ago | 9 | 2021 | Jon Hu Co-Founder | — | 2 patents Corporate e‑learning platforms with gamified, group‑based training and assessment tools | — |
| 34 | 123 See Retailer of health and personal care products | $8M | 25 mo ago | — | 2020 | Matthias Hofmann Co-CEO | — | — | — |
| 35 | Leuko Manufacturer of WBC monitoring device | $7M | 22 mo ago | 15 | 2017 | Carlos Gonzalez Co-Founder & CEO | — | 15 patents Non‑invasive optical capillary imaging for automated white blood cell detection and classification | — |
| 36 | Lifordi Biotechnology company developing treatments for autoimmune and inflammatory disorders using antibody-drug… 45Funding top 45%Talent bottom 49%Global bottom 36% All 3 signals ▾Fundingtop 45% Talentbottom 49% Globalbottom 36% Funding: Raised $5.9M across 2 rounds · 2 rounds over 3 yrs (0.7/yr) Talent: 1 named leader on record · 1 C-suite/founder profile curated rank vs industry peers · Fliar Intelligence Index 45/100 | $6M | 6 mo ago | — | 2023 | Arthur Tzianabos CEO | — | — | — |
| 37 | MAKScientific Targeting the endocannabinoid system for the treatment of metabolic disorders, pain, addiction, and… | $6M | 13 mo ago | — | 2004 | Alexandros Makriyannis Co-Founder | — | 22 patents Therapeutic small‑molecule drugs and formulations for addiction, cannabinoid toxicity, and fibrosis | — |
| 38 | Boston Cell Standards Manufacturer of IHC testing products | $5M | 16 mo ago | 6 | 2003 | Steve Bogen Co-Founder & President & CEO | — | — | — |
| 39 | Alleviate Manufacturer of plantar fasciitis systems | $4M | 29 mo ago | 8 | 2020 | Roderick McMullen Co-Founder | PageFlyUnbounceCart Functionality+36 | 7 patents Therapeutic foot orthoses and massage devices for chronic pain relief | — |
| 40 | FamilyWell Health Provider of integrated perinatal mental health services for OB clinics. 45Growth top 28%Funding top 41%Tech top 50%Talent bottom 49% All 7 signals ▾Growthtop 28% Fundingtop 41% Techtop 50% Talentbottom 49% Moatbottom 38% Globalbottom 29% Marketbottom 27% Growth: Web rank 50,000,000 → 10,000,000 YoY · Fresh capital in last 24 mo Funding: Raised $4.3M across 2 rounds · 2 rounds over 2 yrs (1.0/yr) rank vs industry peers · Fliar Intelligence Index 45/100 | $4M | 7 mo ago | — | 2022 | Jessica Gaulton Founder & CEO | Cart FunctionalitySquarespace CommerceSquarespace+19 | — | — |
| 41 | Guided Clinical Solutions Provider of patient outcomes and guided clinical solutions | $3M | 12 mo ago | 2 | 2022 | Karen Nanji Co-Founder | — | — | — |
| 42 | Centering Healthcare Institute Provider of patient education services | $3M | 14 mo ago | 37 37 → 54 (+46%) | 2001 | Sharon Schindler Rising Founder | Cart FunctionalityCraft CMSApple iCloud Mail+23 | — | 1 partnership |
| 43 | Atalan Provider of healthcare tracking solution and machine learning based turnover prediction services | $3M | 32 mo ago | 8 | 2021 | Bart Blackburn Co-Founder & CSO | WordPressApple iCloud MailGoogle Workspace+22 | — | 1 launch |
| 44 | Zip Run Online platform for THC and CBD products | $3M | 32 mo ago | 6 | 2020 | — | WordPressMySQLPHP+16 | — | — |
| 45 | Connective Health Provider of clinical quality measurement, risk adjustment scores, and health plan services | $2M | 20 mo ago | 10 | 2021 | — | WordPressApple iCloud MailGoogle Workspace+22 | — | — |
| 46 | AxmedRx Manufacturer of drugs | $2M | 25 mo ago | — | 2023 | Sofia Radley-Searle Co-Founder | — | — | — |
| 47 | EMBioSys Developer of non-invasive wearable technology for induced electric field cancer therapy | $2M | 6 mo ago | — | 2022 | Vish Subramaniam Co-Founder & CSO | — | — | — |
| 48 | Surgicure Technologies Manufacturer of breathing tubes and other medical devices 9Funding top 44%Talent bottom 49%Global bottom 36%News bottom 18% All 5 signals ▾Fundingtop 44% Talentbottom 49% Globalbottom 36% Newsbottom 18% Marketbottom 11% Funding: Raised $1.7M across 3 rounds · 3 rounds over 2 yrs (1.5/yr) Talent: 1 named leader on record · 1 C-suite/founder profile curated rank vs industry peers · Fliar Intelligence Index 9/100 | $2M | 15 mo ago | 4 | 2018 | Irena King Founder & CEO | — | — | 1 launch · 2 partnerships · 4 awards |
| 49 | PHI Manufacturer of holographic imaging devices | $1M | 20 mo ago | 14 | 2004 | — | WordPress Block EditorWordPressMySQL+10 | — | — |
| 50 | Ayana Bio Manufacturer of nutritional supplements | $1M | 14 mo ago | 13 | 2021 | Frank Jaksch CEO | — | — | 2 awards |
Top 12 Healthcare companies in Boston
#1
Series B · Boston, Massachusetts · founded 2014 · 4 employees$90.2Mraised▾
Imbria Pharmaceuticals provides therapeutics solution by translation the cellular metabolism. It is involved in providing transformative medicine, by altering the cellular metabolism and mitochondrial function.
- Nov 2025Series B—
- Mar 2025Series B$66.7M
- Jul 2019Series B$50M
- Jul 2018Series B$40.2M
#2
Series A · Boston, Massachusetts · founded 2022$153Mraised▾
Superluminal Medicines Inc. is a biotechnology research company based in Boston, Massachusetts. They specialize in generative biological and chemical solutions for drug discovery programs. The company recently launched with a $33 million seed round to fuel its drug discovery engine and pipeline of small molecule therapeutics.
- Aug 2025Series A$5M
- Aug 2024Series A$120M
- Aug 2023Seed$33M
#3
Series A · Boston, Massachusetts · founded 2026$19Mraised▾
Provider of outpatient treatment centers focusing on CAR-T and T-cell engagers. The organization builds and operates treatment facilities in partnership with health systems. It aims to expand access to advanced therapeutics by developing innovative outpatient centers. The platform integrates patient selection, remote monitoring, and standardized clinical protocols.
- Mar 2026Series A$19M
#4
Series B · Boston, Massachusetts · founded 2018 · 18 employees$68.3Mraised▾
Manufacturer of diagnostic test devices
- Sep 2025Series B$59M
- Apr 2023Series A$41M
- Jan 2021Series A$27.3M
#5
Series A · Boston, Massachusetts · founded 2021$11.4Mraised▾
Company that provides integrated point-of-care testing solutions and AI-powered technology
- Jan 2026Angel$8M
- Jan 2025Series A$3.4M
#6
Series B · Boston, Massachusetts · founded 2018$28.8Mraised▾
Grouper is a social fitness benefit offered by health plans that pays members to have fun with their social groups or clubs. It covers annual group or club membership dues and provides a catalog of clubs to explore and join based on zip code.
- Sep 2025Series B$2.9M
- Oct 2024Series B$18.6M
- Jul 2023Series A$10.2M
- 2018Seed—
#7
Seed · Boston, Massachusetts · founded 2023$5.9Mraised▾
Lifordi is a biotechnology company that develops treatments for autoimmune and inflammatory disorders using antibody-drug conjugates. They have experienced leadership in drug development, immunology, and inflammatory disorders. Lifordi Immunotherapeutics is led by CEO Arthur Tzianabos.
- Nov 2025Seed—
- Sep 2025Grant (prize money)$3M
- Jun 2023Grant (prize money)$3M
#8
Series A · Boston, Massachusetts · founded 2022$4.3Mraised▾
{}
- Nov 2025Series A$8M
- Feb 2024Seed$4.3M
#9
Series A · Boston, Massachusetts · founded 2024$17.5Mraised▾
Provider of automated bioanalysis platform for accelerated clinical drug development. It leverages AI and robotics to deliver high-quality assays with faster turnaround times for clinical trials and GLP studies. The company automates critical steps in bioanalysis, reducing costs and time to market. It focuses on clinical bioanalysis, specifically the testing of samples from clinical trial subjects. The platform integrates quality, automation, and regulatory compliance to enhance customer experience and outcomes.
- Jun 2025Series A$11M
- Oct 2024Seed$6.5M
#10
Series B · Boston, Massachusetts · founded 1987 · 335 employees$25Mraised▾
Provider of health care services intended to provide quality health care globally to those who need it most. The company operates a nonprofit organization that provides preferential options for the poor and marginalized individuals in the healthcare sector, enabling patients to meet their physical, mental, emotional, and daily needs so that they can recover from illness and maintain good health.
- Feb 2025Grant (prize money)$20.6M
- 2023Grant (prize money)—
- Oct 2022Series B$25M
- 2021Grant (prize money)$11.2M
#11
Series B · Boston, Massachusetts · founded 2019 · 20 employees$34Mraised▾
R&D company focused on manufacturing drugs for multiple therapeutic areas
- Jan 2025Series B$6.5M
- Nov 2024Series B$4M
- Jul 2022Series B$34M
#12
Acquired · Boston, Massachusetts · founded 2018 · 3 employees$36.9Mraised▾
Provider of cancer drugs development services
- Dec 2024Grant (prize money)$35.5M
- Sep 2024Grant (prize money)$1.4M
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Healthcare coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising